Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IFI2
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008684 | 2-oxopent-4-enoate hydratase activity | 5 | 1 |
GO:0016829 | lyase activity | 2 | 1 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 1 |
GO:0016836 | hydro-lyase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.459 |
CLV_PCSK_KEX2_1 | 179 | 181 | PF00082 | 0.498 |
CLV_PCSK_PC1ET2_1 | 179 | 181 | PF00082 | 0.482 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.456 |
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.442 |
DEG_APCC_DBOX_1 | 1 | 9 | PF00400 | 0.666 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.639 |
DOC_CKS1_1 | 206 | 211 | PF01111 | 0.468 |
DOC_CKS1_1 | 240 | 245 | PF01111 | 0.432 |
DOC_PP4_FxxP_1 | 149 | 152 | PF00568 | 0.384 |
DOC_USP7_UBL2_3 | 224 | 228 | PF12436 | 0.518 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.440 |
DOC_WW_Pin1_4 | 205 | 210 | PF00397 | 0.419 |
DOC_WW_Pin1_4 | 236 | 241 | PF00397 | 0.348 |
LIG_14-3-3_CanoR_1 | 187 | 197 | PF00244 | 0.519 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.582 |
LIG_14-3-3_CanoR_1 | 258 | 264 | PF00244 | 0.468 |
LIG_14-3-3_CanoR_1 | 96 | 102 | PF00244 | 0.502 |
LIG_BRCT_BRCA1_1 | 3 | 7 | PF00533 | 0.524 |
LIG_BRCT_BRCA1_1 | 90 | 94 | PF00533 | 0.311 |
LIG_deltaCOP1_diTrp_1 | 252 | 256 | PF00928 | 0.436 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.495 |
LIG_FHA_1 | 209 | 215 | PF00498 | 0.427 |
LIG_FHA_1 | 258 | 264 | PF00498 | 0.458 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.368 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.410 |
LIG_LIR_Gen_1 | 208 | 218 | PF02991 | 0.457 |
LIG_LIR_Gen_1 | 260 | 265 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 145 | 150 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 17 | 21 | PF02991 | 0.394 |
LIG_LIR_Nem_3 | 208 | 213 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 252 | 256 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 260 | 264 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.445 |
LIG_LYPXL_yS_3 | 61 | 64 | PF13949 | 0.417 |
LIG_Pex14_2 | 90 | 94 | PF04695 | 0.331 |
LIG_SH2_CRK | 261 | 265 | PF00017 | 0.368 |
LIG_SH2_STAP1 | 219 | 223 | PF00017 | 0.371 |
LIG_SH2_STAP1 | 249 | 253 | PF00017 | 0.452 |
LIG_SH2_STAT3 | 21 | 24 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.334 |
LIG_SH3_3 | 237 | 243 | PF00018 | 0.403 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.327 |
LIG_SH3_3 | 82 | 88 | PF00018 | 0.357 |
LIG_Sin3_3 | 210 | 217 | PF02671 | 0.449 |
LIG_TRAF2_1 | 55 | 58 | PF00917 | 0.424 |
LIG_TYR_ITIM | 259 | 264 | PF00017 | 0.412 |
LIG_UBA3_1 | 89 | 97 | PF00899 | 0.419 |
MOD_CDK_SPK_2 | 236 | 241 | PF00069 | 0.376 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.545 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.462 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.447 |
MOD_CK1_1 | 239 | 245 | PF00069 | 0.418 |
MOD_CK2_1 | 122 | 128 | PF00069 | 0.418 |
MOD_GlcNHglycan | 141 | 145 | PF01048 | 0.465 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.412 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.597 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.449 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.437 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.369 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.473 |
MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.462 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.526 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.369 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.449 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.412 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.465 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.468 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.460 |
MOD_NEK2_2 | 75 | 80 | PF00069 | 0.507 |
MOD_PIKK_1 | 79 | 85 | PF00454 | 0.445 |
MOD_PK_1 | 97 | 103 | PF00069 | 0.456 |
MOD_PKA_1 | 179 | 185 | PF00069 | 0.464 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.607 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.464 |
MOD_PKA_2 | 257 | 263 | PF00069 | 0.446 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.358 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.353 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.499 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.434 |
MOD_Plk_2-3 | 122 | 128 | PF00069 | 0.510 |
MOD_Plk_2-3 | 28 | 34 | PF00069 | 0.515 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.404 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.405 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.438 |
MOD_ProDKin_1 | 205 | 211 | PF00069 | 0.419 |
MOD_ProDKin_1 | 236 | 242 | PF00069 | 0.348 |
MOD_SUMO_for_1 | 178 | 181 | PF00179 | 0.421 |
MOD_SUMO_rev_2 | 110 | 120 | PF00179 | 0.353 |
TRG_DiLeu_BaLyEn_6 | 59 | 64 | PF01217 | 0.429 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.357 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.493 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7W6 | Leptomonas seymouri | 64% | 100% |
A0A0S4KNC9 | Bodo saltans | 22% | 100% |
A0A1X0P382 | Trypanosomatidae | 39% | 99% |
A0A422NIG2 | Trypanosoma rangeli | 38% | 99% |
A4HI22 | Leishmania braziliensis | 91% | 100% |
A4I599 | Leishmania infantum | 100% | 100% |
C9ZQN0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 99% |
E9B0J5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4Q7N7 | Leishmania major | 98% | 100% |
Q584U2 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 38% | 99% |
V5BC65 | Trypanosoma cruzi | 38% | 99% |